Eltrombopag Tablet, Film Coated
Product Images NDC 72205-157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 72205-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eltrombopag-tabs-12-5-30s-label (Eltrombopag Tabs 12 5 30s Label)

Eltrombopag-tabs-12-5-30s-label (Eltrombopag Tabs 12 5 30s Label)
This is a prescription medication called Eltrombopag in tablet form, with each tablet containing 12.5 mg of the active ingredient. The instructions advise swallowing the tablets whole and not splitting, chewing, or crushing them. It is essential to dispense the Medication Guide to each patient. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (69°F to 86°F). The medicine should be kept in the original bottle and should not be used if the safety seal is broken. Safety closures are recommended when dispensing the product. The manufacturer is MSN Laboratories Private Limited in India, and it is distributed by Novadoz Pharmaceuticals LLC in Piscataway, New Jersey. The medication guide can be printed from the provided link.*
FDA Label Image

Eltrombopag-tabs-25-30s-label (Eltrombopag Tabs 25 30s Label)

Eltrombopag-tabs-25-30s-label (Eltrombopag Tabs 25 30s Label)
This text provides information on a medication called Eltrombopag in tablet form, with each tablet containing 25mg of eltrombopag olamine equivalent to 25mg of eltrombopag free acid. It instructs to swallow the tablets whole and not to split, chew, or crush them. The medication guide should be dispensed separately to each patient. It also includes storage instructions, dosage details, and safety information such as checking for a printed safety seal under the cap and using safety closures. The medication is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in the United States. It provides contact information for Novadoz Pharmaceuticals and a website for product information.*
FDA Label Image

Eltrombopag-tabs-50-14s-label (Eltrombopag Tabs 50 14s Label)

Eltrombopag-tabs-50-14s-label (Eltrombopag Tabs 50 14s Label)
This is a medication guide for Eltrombopag tablets, each containing 50 mg of Eltrombopag free acid. The tablets should be swallowed whole and not split, chewed, or crushed. The dosage information can be found in the accompanying prescribing information. The medication should be stored at room temperature and dispensed in the original bottle. Safety closures should be used, and the product should be kept out of reach of children. The tablets are manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in the USA. More information can be found on their website.*
FDA Label Image

Eltrombopag-tabs-50-30s-label (Eltrombopag Tabs 50 30s Label)

Eltrombopag-tabs-50-30s-label (Eltrombopag Tabs 50 30s Label)
This text is a label for eltrombopag tablets, including instructions for use and storage. It also provides information about the dosage, manufacturer, distributor, and safety precautions. It is advised to swallow the tablets whole, store them at room temperature, dispense in the original bottle, and use safety closures. The manufacturer is MSN Laboratories Private Limited in India, and the distributor is Novadoz Pharmaceuticals LLC in Piscataway, NJ. Make sure to always read and follow the provided Medication Guide.*
FDA Label Image

Eltrombopag-tabs-75-30s-label (Eltrombopag Tabs 75 30s Label)

Eltrombopag-tabs-75-30s-label (Eltrombopag Tabs 75 30s Label)
This is a prescription drug with the active ingredient Eltrombopag, provided in tablet form. Patients are advised to swallow the tablets whole and not to split, chew, or crush them. The medication guide should be dispensed to each patient separately. Each tablet contains eltrombopag olamine equivalent to 75 mg of eltrombopag free acid. The dosage information can be found in the accompanying Prescribing Information. The tablets should be stored at room temperature between 20°C to 25°C (68°F to 77°F). Dispense in the original bottle and do not use if the safety seal under the cap is broken or missing. Safety closures should be used when dispensing the product. The medication is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in the USA. For more information, visit www.NovadozPharma.com/Products.*
FDA Label Image

Eltrombopag-tabs-structure (Eltrombopag Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.